1019O Phase I studies of Sym021, an anti-PD-1 antibody, alone and in combination with Sym022 (anti-LAG-3) or Sym023 (anti-TIM-3)

N. Lakhani,A. Spreafico,A.W. Tolcher,J. Rodon,F. Janku, S.R. Chandana,M. Oliva, M. Sharma, R.M. Abdul-Karim, U.H. Hansen, L. Hansen, N.J.Ø. Skartved,T.T. Poulsen, R.P. Nadal,J. Lantto, D.L. Wood,P.I. Nadler,L.L. Siu

Annals of Oncology（2020）

Cited 0|Views0

No score

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined